VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 160 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $512,000 | -36.8% | 49,380 | 0.0% | 0.02% | -38.5% |
| Q4 2019 | $810,000 | +24.6% | 49,380 | +0.9% | 0.03% | +4.0% |
| Q3 2019 | $650,000 | -5.4% | 48,950 | +0.4% | 0.02% | -47.9% |
| Q2 2019 | $687,000 | +141.1% | 48,760 | +215.0% | 0.05% | +152.6% |
| Q1 2019 | $285,000 | -28.0% | 15,480 | +2.2% | 0.02% | -17.4% |
| Q4 2018 | $396,000 | – | 15,150 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |